Northeast, New York Julia Travagline 12/14/25 Northeast, New York Julia Travagline 12/14/25

Targeting ALT-Associated Vulnerabilities in Pediatric High-Grade Glioma

Targeting ALT-Associated Vulnerabilities in Pediatric High-Grade Glioma

Dr. Jihye Paik, Ph.D. – Weill Medical College of Cornell University, New York, NY

Read More

Northeast, New York Julia Travagline 12/14/25 Northeast, New York Julia Travagline 12/14/25

Precision Epigenetic Therapies for Pediatric Burkitt Lymphoma

Precision Epigenetic Therapies for Pediatric Burkitt Lymphoma

Dr. Darko Barisic, Ph.D. – Weill Medical College of Cornell University, New York, NY

Read More

Northeast, New York Julia Travagline 11/20/24 Northeast, New York Julia Travagline 11/20/24

HBEGF as a novel therapeutic target for Diffuse Midline Glioma

HBEGF as a novel therapeutic target for Diffuse Midline Glioma

Dr. Oren Becher, M.D. – Icahn School of Medicine at Mount Sinai, New York, NY

Read More

New York, Northeast Julia Travagline 11/20/24 New York, Northeast Julia Travagline 11/20/24

The impact of UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia

The impact of UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia

Dr. lannis Aifantis, Ph.D. – New York University Grossman School of Medicine, New York, NY

Read More

Northeast, New York Julia Travagline 11/20/24 Northeast, New York Julia Travagline 11/20/24

The Role of S100A8/A9-IL6R in B-ALL Chemoresistance

The Role of S100A8/A9-IL6R in B-ALL Chemoresistance

Dr. William Carroll, M.D. – New York University Grossman School of Medicine, New York, NY

Read More

Northeast, New York Julia Travagline 11/22/23 Northeast, New York Julia Travagline 11/22/23

Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma

Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma

Dr. Oren Becher – Icahn School of Medicine at Mount Sinai, New York, NY

Read More

Northeast, New York Julia Travagline 12/14/22 Northeast, New York Julia Travagline 12/14/22

Therapeutical reprogramming of DIPG cells

Therapeutical reprogramming of DIPG cells

Joan & Sanford I. Weill Medical College of Cornell University, New York, NY

Read More

Northeast, New York Julia Travagline 12/8/21 Northeast, New York Julia Travagline 12/8/21

T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors

T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors

Memorial Sloan Kettering Cancer Center (MSK), New York, NY

Read More

New York, Northeast Julia Travagline 12/8/21 New York, Northeast Julia Travagline 12/8/21

The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model

The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model

Albert Einstein College of Medicine, New York, NY

Read More

New York, Northeast Julia Travagline 8/10/21 New York, Northeast Julia Travagline 8/10/21

Arginine methylation as a potential therapeutic target in high-risk neuroblastoma

Arginine methylation as a potential therapeutic target in high-risk neuroblastoma

University of Rochester, Rochester, NY

Read More

New York, Northeast Julia Travagline 8/9/21 New York, Northeast Julia Travagline 8/9/21

Disrupting Neuroblastoma Tumor-Initiating Cells

Disrupting Neuroblastoma Tumor-Initiating Cells

University of Rochester, Rochester, NY

Read More

New York, Northeast Julia Travagline 8/9/21 New York, Northeast Julia Travagline 8/9/21

Tumorigenesis of a Pediatric Liver Cancer

Tumorigenesis of a Pediatric Liver Cancer

The Rockefeller University, New York, NY

Read More